Login / Signup

[18 F]Fluoroethoxybenzovesamicol in Parkinson's disease patients: Quantification of a novel cholinergic positron emission tomography tracer.

Sygrid van der ZeeDavid Vállez GarcíaPhilip H ElsingaAntoon T M WillemsenHendrikus H BoersmaMarleen J J GerritsenJacoba M SpikmanTeus van Laar
Published in: Movement disorders : official journal of the Movement Disorder Society (2019)
Keyphrases
  • positron emission tomography
  • computed tomography
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • prognostic factors
  • pet ct
  • patient reported outcomes